Zynerba Pharmaceuticals to Present at Two January Virtual Investor Conferences

Zynerba Pharmaceuticals

DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, announced that Armando Anido, Chief Executive Officer of Zynerba, will participate in two upcoming virtual investor conferences.

Mr. Anido will participate in a fireside chat during the H.C. Wainwright BioConnect Conference which will be available on-demand January 11-14, 2021. He will also present a company overview during the ICR Conference 2021 on Thursday, January 14, 2021, at 10:00 a.m. ET.

Investors interested in arranging a virtual meeting with the Company’s management during the ICR Conference 2021 should contact the conference coordinator or [email protected].

Webcasts of both conferences will be accessible under the Events & Webcasts tab of the Investor section of Zynerba’s website at www.zynerba.com.

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.